FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

14783511000001107: Ranitidine 300mg tablets (LPC Medical (UK) Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2009. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
51760401000001118 Ranitidine 300mg tablets (LPC Medical (UK) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
69340601000001118 Ranitidine 300mg tablets (Boston Healthcare Ltd) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) Is a Product containing precisely ranitidine (as ranitidine hydrochloride) 300 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) Has active ingredient Ranitidine hydrochloride false Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) Has specific active ingredient Ranitidine hydrochloride true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) Has basis of strength substance Ranitidine true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) 30 tablet 3 x 10 tablets Is pack of False Ranitidine 300mg tablets (LPC Medical (UK) Ltd) Inferred relationship Existential restriction modifier
Ranitidine 300mg tablets (LPC Medical (UK) Ltd) 30 tablet 3 x 10 tablets Has AMP True Ranitidine 300mg tablets (LPC Medical (UK) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start